Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Design Therapeutics, Inc. (DSGN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-20.16M |
|
-- |
|
-- |
|
$22.18M |
|
$-22.18M |
|
$2.01M |
|
$-20.16M |
|
$-20.16M |
|
$-20.16M |
|
$-20.16M |
|
$-20.16M |
|
$-20.16M |
|
$-22.18M |
|
$-22.04M |
|
62.51M |
|
62.51M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$212.01M |
|
$0.69M |
|
$3.12M |
|
$215.13M |
|
$11.24M |
|
-- |
|
$2.03M |
|
$13.27M |
|
$201.86M |
|
$201.86M |
|
$201.86M |
|
62.58M |
|
| Cash Flow Statement Financials | |
$-31.95M |
|
$7.47M |
|
$20.54M |
|
$16.86M |
|
$12.91M |
|
$-3.95M |
|
$7.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.86 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.99% |
|
-9.99% |
|
-9.37% |
|
-9.99% |
|
$3.23 |
|
$-0.51 |
|
$-0.51 |
|